PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.58%
Revenue growth of 8.58% while 1097.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
26.76%
Gross profit growth of 26.76% while 1097.HK is zero. Bruce Berkowitz would see if minimal improvements could expand further.
No Data
No Data available this quarter, please select a different quarter.
-1779.25%
Negative operating income growth while 1097.HK is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
61.69%
Net income growth of 61.69% while 1097.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
55.26%
EPS growth of 55.26% while 1097.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
58.36%
Diluted EPS growth of 58.36% while 1097.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
19.83%
Share change of 19.83% while 1097.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
14.75%
Diluted share change of 14.75% while 1097.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-16.55%
Dividend reduction while 1097.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
0.00%
OCF growth of 0.00% while 1097.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
0.00%
FCF growth of 0.00% while 1097.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
9.72%
10Y CAGR of 9.72% while 1097.HK is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-57.50%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-52.32%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
210.73%
OCF/share CAGR of 210.73% while 1097.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-25.62%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
2100.08%
Positive 3Y OCF/share CAGR while 1097.HK is negative. John Neff might see a big short-term edge in operational efficiency.
232.25%
10Y net income/share CAGR of 232.25% while 1097.HK is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-75.58%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
140.36%
Positive short-term CAGR while 1097.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.53%
Dividend/share CAGR of 2.53% while 1097.HK is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-53.47%
Negative 5Y dividend/share CAGR while 1097.HK stands at 65.17%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while 1097.HK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.